4//SEC Filing
Robichaud Albert 4
Accession 0001562180-23-001082
CIK 0001597553other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:11 PM ET
Size
8.9 KB
Accession
0001562180-23-001082
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-02-03+3,375→ 146,680 total - Tax Payment
Common Stock
2023-02-03$44.16/sh−1,127$49,768→ 145,553 total
Footnotes (2)
- [F1]On February 10, 2021, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 11,250 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on February 3, 2023, resulting in the vesting of the PSUs as to 3,375 shares.
- [F2]Reflects beneficial ownership balance which includes 279 shares purchased on June 30, 2022 and 397 shares purchased on December 31, 2022, each under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612861
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:11 PM ET
- Size
- 8.9 KB